Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 26, 2017

DrugPatentWatch Database Preview

BENZONATATE Drug Profile

« Back to Dashboard

What is the patent landscape for Benzonatate, and when can generics launch?

Benzonatate is a drug marketed by Thepharmanetwork Llc, Apotex Inc, The Pharma Network, Strides Pharma, Mikart, Cspc Nbp Pharm Co, Orit Labs Llc, Sun Pharm Inds Inc, Nesher Pharms, Bionpharma Inc, and Zydus Pharms Usa. and is included in twelve NDAs.

The generic ingredient in BENZONATATE is benzonatate. There are six drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the benzonatate profile page.

Summary for Tradename: BENZONATATE

Patents:0
Applicants:11
NDAs:12
Suppliers / Packagers: see list52
Bulk Api Vendors: see list18
Patent Applications: see list1,035
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:BENZONATATE at DailyMed

Pharmacology for Tradename: BENZONATATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Thepharmanetwork Llc
BENZONATATE
benzonatate
CAPSULE;ORAL201209-001Sep 24, 2014AARXNoYes► Subscribe► Subscribe
Bionpharma Inc
BENZONATATE
benzonatate
CAPSULE;ORAL081297-001Jan 29, 1993AARXNoNo► Subscribe► Subscribe
The Pharma Network
BENZONATATE
benzonatate
CAPSULE;ORAL040749-001Jul 25, 2007AARXNoYes► Subscribe► Subscribe
The Pharma Network
BENZONATATE
benzonatate
CAPSULE;ORAL040627-001Mar 30, 2007AARXNoYes► Subscribe► Subscribe
Orit Labs Llc
BENZONATATE
benzonatate
CAPSULE;ORAL040682-001Jul 30, 2007AARXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot